ProQR Therapeutics N.V.

The current price of PRQR is 2.09 USD — it has increased by 4.50% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ProQR Therapeutics N.V. stocks are traded under the ticker PRQR.

ProQR Therapeutics N.V. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

PRQR stock is 5.97% volatile and has beta coefficient of 1.21. Check out the list of the most volatile stocks — is ProQR Therapeutics N.V. there?

PRQR earnings for the last quarter are −0.07 USD per share, whereas the estimation was −0.09 USD resulting in a 18.36% surprise. The estimated earnings for the next quarter are 0.02 USD per share. See more details about ProQR Therapeutics N.V. earnings.

ProQR Therapeutics N.V. revenue for the last quarter amounts to ‪1.45 M‬ USD despite the estimated figure of ‪4.89 M‬ USD. In the next quarter revenue is expected to reach ‪17.43 M‬ USD.

Yes, you can track ProQR Therapeutics N.V. financials in yearly and quarterly reports right on TradingView.

PRQR stock has risen by 4.50% compared to the previous week, the month change is a 11.81% fall, over the last year ProQR Therapeutics N.V. has showed a 8.33% decrease.

Today ProQR Therapeutics N.V. has the market capitalization of ‪161.63 M‬, it has increased by 3.67% over the last week.

No, PRQR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, PRQR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ProQR Therapeutics N.V. stock right from TradingView charts — choose your broker and connect to your account.

PRQR reached its all-time high on Mar 16, 2015 with the price of 27.60 USD, and its all-time low was 0.53 USD and was reached on May 11, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 23, 2024, the company has 156.00 employees. See our rating of the largest employees — is ProQR Therapeutics N.V. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ProQR Therapeutics N.V. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ProQR Therapeutics N.V. stock shows the sell signal. See more of ProQR Therapeutics N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on ProQR Therapeutics N.V. future price: according to them, PRQR price has a max estimate of 5.85 USD and a min estimate of 2.01 USD. Read a more detailed ProQR Therapeutics N.V. forecast: see what analysts think of ProQR Therapeutics N.V. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ProQR Therapeutics N.V. EBITDA is ‪−34.97 M‬ USD, and current EBITDA margin is −496.73%. See more stats in ProQR Therapeutics N.V. financial statements.